SEARCH

SEARCH BY CITATION

References

  • 1
    Stupp R,Hegi ME,Mason WP,van den Bent MJ,Taphoorn MJ,Janzer RC,Ludwin SK,Allgeier A,Fisher B,Belanger K,Hau P,Brandes AA, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 45966.
  • 2
    Godard S,Getz G,Delorenzi M,Farmer P,Kobayashi H,Desbaillets I,Nozaki M,Diserens AC,Hamou MF,Dietrich PY,Regli L,Janzer RC, et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003; 63: 661325.
  • 3
    Li A,Walling J,Ahn S,Kotliarov Y,Su Q,Quezado M,Oberholtzer JC,Park J,Zenklusen JC,Fine HA. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 2009; 69: 20919.
  • 4
    Basil CF,Zhao Y,Zavaglia K,Jin P,Panelli MC,Voiculescu S,Mandruzzato S,Lee HM,Seliger B,Freedman RS,Taylor PR,Hu N, et al. Common cancer biomarkers. Cancer Res 2006; 66: 295361.
  • 5
    Selander KS,Brown DA,Sequeiros GB,Hunter M,Desmond R,Parpala T,Risteli J,Breit SN,Jukkola-Vuorinen A. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev 2007; 16: 5327.
  • 6
    Talantov D,Mazumder A,Yu JX,Briggs T,Jiang Y,Backus J,Atkins D,Wang Y. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11: 723442.
  • 7
    Welsh JB,Sapinoso LM,Kern SG,Brown DA,Liu T,Bauskin AR,Ward RL,Hawkins NJ,Quinn DI,Russell PJ,Sutherland RL,Breit SN, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003; 100: 341015.
  • 8
    Brown DA,Ward RL,Buckhaults P,Liu T,Romans KE,Hawkins NJ,Bauskin AR,Kinzler KW,Vogelstein B,Breit SN. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9: 264250.
  • 9
    de Wit NJ,Rijntjes J,Diepstra JH,van Kuppevelt TH,Weidle UH,Ruiter DJ,van Muijen GN. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer 2005; 92: 224961.
  • 10
    Grote T,Logsdon CD. Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol 2007; 23: 50814.
  • 11
    Nakamura T,Scorilas A,Stephan C,Yousef GM,Kristiansen G,Jung K,Diamandis EP. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer 2003; 88: 11014.
  • 12
    Brown DA,Stephan C,Ward RL,Law M,Hunter M,Bauskin AR,Amin J,Jung K,Diamandis EP,Hampton GM,Russell PJ,Giles GG, et al. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin Cancer Res 2006; 12: 8996.
  • 13
    Bootcov MR,Bauskin AR,Valenzuela SM,Moore AG,Bansal M,He XY,Zhang HP,Donnellan M,Mahler S,Pryor K,Walsh BJ,Nicholson RC, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 1997; 94: 1151419.
  • 14
    Fairlie WD,Moore AG,Bauskin AR,Russell PK,Zhang HP,Breit SN. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999; 65: 25.
  • 15
    Hromas R,Hufford M,Sutton J,Xu D,Li Y,Lu L. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1997; 1354: 404.
  • 16
    Lawton LN,Bonaldo MF,Jelenc PC,Qiu L,Baumes SA,Marcelino RA,de Jesus GM,Wellington S,Knowles JA,Warburton D,Brown S,Soares MB. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 1997; 203: 1726.
  • 17
    Paralkar VM,Vail AL,Grasser WA,Brown TA,Xu H,Vukicevic S,Ke HZ,Qi H,Owen TA,Thompson DD. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 1998; 273: 137607.
  • 18
    Strelau J,Sullivan A,Bottner M,Lingor P,Falkenstein E,Suter-Crazzolara C,Galter D,Jaszai J,Krieglstein K,Unsicker K. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 2000; 20: 8597603.
  • 19
    Ravussin P,Mustaki JP,Boulard G,Moeschler O. Neuro-anesthetic contribution to the prevention of complications caused by mechanical cerebral retraction: concept of a chemical brain retractor. Ann Fr Anesth Reanim 1995; 14: 4955.
  • 20
    Ostermann S,Csajka C,Buclin T,Leyvraz S,Lejeune F,Decosterd LA,Stupp R. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 2004; 10: 372836.
  • 21
    Brown DA,Bauskin AR,Fairlie WD,Smith MD,Liu T,Xu N,Breit SN. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 2002; 33: 11820,22,24.
  • 22
    Moore AG,Brown DA,Fairlie WD,Bauskin AR,Brown PK,Munier ML,Russell PK,Salamonsen LA,Wallace EM,Breit SN. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 2000; 85: 47818.
  • 23
    Albertoni M,Shaw PH,Nozaki M,Godard S,Tenan M,Hamou MF,Fairlie DW,Breit SN,Paralkar VM,de Tribolet N,Van Meir EG,Hegi ME. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002; 21: 421219.
  • 24
    Jones G,Machado J,Jr,Merlo A. Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res 2001; 61: 497881.
  • 25
    Hegi ME,Diserens AC,Gorlia T,Hamou MF,de Tribolet N,Weller M,Kros JM,Hainfellner JA,Mason WP,Mariani L,Bromberg JEC,Hau P, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 9971003.
  • 26
    Fabriek BO,van Haastert ES,Galea I,Polfliet MM,Dopp ED,van Den Heuvel MM,van Den Berg TK,De Groot CJ,van Der Valk P,Dijkstra CD. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005; 51: 297305.
  • 27
    Murat A,Migliavacca E,Gorlia T,Lambiv WL,Shay T,Hamou MF,de Tribolet N,Regli L,Wick W,Kouwenhoven MC,Hainfellner JA,Heppner FL, et al. Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008; 26: 301524.
  • 28
    Strelau J,Schmeer C,Peterziel H,Sackmann T,Herold-Mende C,Steiner H,Weller M,Unsicker K. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett 2008; 270: 309.
  • 29
    Tso CL,Freije WA,Day A,Chen Z,Merriman B,Perlina A,Lee Y,Dia EQ,Yoshimoto K,Mischel PS,Liau LM,Cloughesy TF, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006; 66: 15967.
  • 30
    Sundstrom C,Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 56577.
  • 31
    Hussain SF,Yang D,Suki D,Aldape K,Grimm E,Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncol 2006; 8: 26179.
  • 32
    Murat A,Migliavacca E,Desbaillets I,Hussain SF,Heimberger AB,Hamou M-F,Rüegg C,Stupp R,Delorenzi M,Hegi ME. Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS ONE 2009; 4: e5947.
  • 33
    Albertoni M,Shaw PH,Nozaki M,Godard S,Tenan M,Hamou M-F,Fairlie WD,Breit SN,Paralkar VM,de Tribolet N,Van Meir EG,Hegi ME. Anoxia induces the macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002; 21: 421219.
  • 34
    Kannan K,Amariglio N,Rechavi G,Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett 2000; 470: 7782.
  • 35
    Li PX,Wong J,Ayed A,Ngo D,Brade AM,Arrowsmith C,Austin RC,Klamut HJ. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000; 275: 2012735.
  • 36
    Ibanez de Caceres I,Dulaimi E,Hoffman AM,Al-Saleem T,Uzzo RG,Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 2006; 66: 50218.
  • 37
    Bauskin AR,Brown DA,Kuffner T,Johnen H,Luo XW,Hunter M,Breit SN. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006; 66: 49836.
  • 38
    Brown DA,Moore J,Johnen H,Smeets TJ,Bauskin AR,Kuffner T,Weedon H,Milliken ST,Tak PP,Smith MD,Breit SN. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum 2007; 56: 75364.
  • 39
    Wollert KC,Kempf T,Lagerqvist B,Lindahl B,Olofsson S,Allhoff T,Peter T,Siegbahn A,Venge P,Drexler H,Wallentin L. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007; 116: 15408.
  • 40
    Tong S,Marjono B,Brown DA,Mulvey S,Breit SN,Manuelpillai U,Wallace EM. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 2004; 363: 12930.
  • 41
    Johnen H,Lin S,Kuffner T,Brown DA,Tsai VW,Bauskin AR,Wu L,Pankhurst G,Jiang L,Junankar S,Hunter M,Fairlie WD, et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 2007; 13: 133340.
  • 42
    Hormigo A,Gu B,Karimi S,Riedel E,Panageas KS,Edgar MA,Tanwar MK,Rao JS,Fleisher M,DeAngelis LM,Holland EC. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res 2006; 12: 5698704.
  • 43
    Dupont J,Tanwar MK,Thaler HT,Fleisher M,Kauff N,Hensley ML,Sabbatini P,Anderson S,Aghajanian C,Holland EC,Spriggs DR. Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol 2004; 22: 33309.
  • 44
    Nikkola J,Vihinen P,Vuoristo MS,Kellokumpu-Lehtinen P,Kahari VM,Pyrhonen S. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 2005; 11: 515866.
  • 45
    Jung CS,Foerch C,Schanzer A,Heck A,Plate KH,Seifert V,Steinmetz H,Raabe A,Sitzer M. Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 2007; 130: 333641.
  • 46
    Brommeland T,Rosengren L,Fridlund S,Hennig R,Isaksen V. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurol Scand 2007; 116: 3804.
  • 47
    Baek SJ,Kim KS,Nixon JB,Wilson LC,Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001; 59: 9018.
  • 48
    Karin M,Cao Y,Greten FR,Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 30110.